Literature DB >> 3919749

Lack of inhibition of purine nucleoside phosphorylase and adenosine deaminase in patients treated with azathioprine.

J L Maddocks, S A Al-Safi.   

Abstract

Deficiency of the purine salvage enzymes purine nucleoside phosphorylase (PNP) and adenosine deaminase (ADA) are known causes of immunodeficiency. Evidence for inhibition of these enzymes was sought in 16 patients on azathioprine therapy by testing for deoxyguanosine (PNP deficiency) and deoxyadenosine (ADA deficiency) in urine using a novel phosphorescence method. These abnormal nucleosides were not found in urine of azathioprine treated patients or in 30 normal controls but were easily detected in urine from proven cases of PNP and ADA deficiency suggesting lack of in vivo inhibition of PNP and ADA by azathioprine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919749      PMCID: PMC1463784          DOI: 10.1111/j.1365-2125.1985.tb02623.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Separation and detection of picomole quantities of azathioprine metabolites.

Authors:  J L Maddocks; G S Davidson
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

2.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

3.  Inhibition of human purine nucleoside phosphorylase. Studies with intact erythrocytes and the purified enzyme.

Authors:  T A Krenitsky; G B Elion; A M Henderson; G H Hitchings
Journal:  J Biol Chem       Date:  1968-06-10       Impact factor: 5.157

4.  Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease.

Authors:  J Donofrio; M S Coleman; J J Hutton; A Daoud; B Lampkin; J Dyminski
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

5.  Urinary excretion of purines, purine nucleosides, and pseudouridine in adenosine deaminase deficiency.

Authors:  G C Mills; R M Goldblum; K E Newkirk; F C Schmalstieg
Journal:  Biochem Med       Date:  1978-10

6.  Purine metabolism and immunodeficiency: urinary purine excretion as a diagnostic screening test in adenosine deaminase and purine nucleoside phosphorylase deficiency.

Authors:  H A Simmonds; A Sahota; C F Potter; J S Cameron
Journal:  Clin Sci Mol Med       Date:  1978-05

7.  Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase.

Authors:  A Cohen; D Doyle; D W Martin; A J Ammann
Journal:  N Engl J Med       Date:  1976-12-23       Impact factor: 91.245

8.  Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency.

Authors:  J W Stoop; B J Zegers; G F Hendrickx; L H van Heukelom; G E Staal; P K de Bree; S K Wadman; R E Ballieux
Journal:  N Engl J Med       Date:  1977-03-24       Impact factor: 91.245

9.  Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity.

Authors:  E R Giblett; A J Ammann; D W Wara; R Sandman; L K Diamond
Journal:  Lancet       Date:  1975-05-03       Impact factor: 79.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.